Induction of HBsAg Decline Using an add-on Treatment of Peginterferon Alfa-2a in HBeAg-negative Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogous (PAS)
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2016
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Adefovir; Entecavir; Tenofovir
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms PAS
- 09 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Oct 2018.
- 09 Aug 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Jun 2018.
- 12 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov.